A deep dive discussion on Abivax with Truist Senior Biotech Analyst Gregory Renza

from BiotechTV - News · host BiotechTV

We discuss the upcoming maintenance data, commercial prospects, Crohn's, and buyout prospects.

Episode metadata supplied by the publisher feed · Published Dec 29, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

A deep dive discussion on Abivax with Truist Senior Biotech Analyst Gregory Renza

0:00 45:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode is 45 minutes long.

This episode was published on December 29, 2025.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!